A. Bateson

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.

P. Butcher, M. Hatherill, S. Charalambous, 2014, The New England journal of medicine.

Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.

A. Crook, Juliano Timm, P. Yablonskiy, 2022, The New England journal of medicine.

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial

A. Witney, P. Butcher, N. Stoker, 2017, BMC Medicine.

Molecular Bacterial Load Assay, a Culture-Free Biomarker for Rapid and Accurate Quantification of Sputum Mycobacterium tuberculosis Bacillary Load during Treatment

P. V. van Helden, S. Gillespie, K. Ronacher, 2011, Journal of Clinical Microbiology.

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens

A. Crook, S. Gillespie, A. Nunn, 2017, BMC Medicine.

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

A. Witney, S. Niemann, Juliano Timm, 2022, The Journal of antimicrobial chemotherapy.

Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid

A. Witney, Ana Paleckyte, M. Olugbosi, 2023, PLOS global public health.